{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:01:45Z","timestamp":1774544505653,"version":"3.50.1"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R15NS130532-01"],"award-info":[{"award-number":["1R15NS130532-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01278-y","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T09:24:33Z","timestamp":1771320273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Testing an inverse link between limbic alpha-synucleinopathy and myelin markers in mice and humans"],"prefix":"10.1038","volume":"12","author":[{"given":"Rachel N.","family":"Clark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reese E.","family":"Landes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muslim","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria G.","family":"Mistretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhanvi R.","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieran A.","family":"DeLoatch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Franks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin C.","family":"Luk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehana K.","family":"Leak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"1278_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K Del Tredici","year":"2002","unstructured":"Del Tredici, K., Rub, U., De Vos, R. A., Bohl, J. R. & Braak, H. Where does parkinson disease pathology begin in the brain? J. Neuropathol. Exp. Neurol. 61, 413\u2013426 (2002).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1278_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-002-1301-4","volume":"249","author":"H Braak","year":"2002","unstructured":"Braak, H. et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages). J. Neurol. 249, 1\u20135 (2002).","journal-title":"J. Neurol."},{"key":"1278_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"1278_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak, H., Rub, U., Gai, W. P. & Del Tredici, K. Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J. Neural Transm. 110, 517\u2013536 (2003).","journal-title":"J. Neural Transm."},{"key":"1278_CR5","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S1474-4422(10)70213-1","volume":"9","author":"E Angot","year":"2010","unstructured":"Angot, E., Steiner, J. A., Hansen, C., Li, J. Y. & Brundin, P. Are synucleinopathies prion-like disorders? Lancet Neurol. 9, 1128\u20131138 (2010).","journal-title":"Lancet Neurol."},{"key":"1278_CR6","doi-asserted-by":"publisher","unstructured":"Burre, J., Sharma, M. & Sudhof, T. C. Cell Biology And Pathophysiology Of Alpha-synuclein. Cold Spring Harb. Perspect. Med. 8, https:\/\/doi.org\/10.1101\/cshperspect.a024091 (2018).","DOI":"10.1101\/cshperspect.a024091"},{"key":"1278_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-015-0549-x","volume":"15","author":"Y Chu","year":"2015","unstructured":"Chu, Y. & Kordower, J. H. The prion hypothesis of Parkinson\u2019s disease. Curr. Neurol. Neurosci. Rep. 15, 28 (2015).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"1278_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00401-019-02057-1","volume":"138","author":"RK Leak","year":"2019","unstructured":"Leak, R. K., Frosch, M. P., Beach, T. G. & Halliday, G. M. Alpha-synuclein: prion or prion-like? Acta Neuropathol. 138, 509\u2013514 (2019).","journal-title":"Acta Neuropathol."},{"key":"1278_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00441-017-2712-y","volume":"373","author":"G Tamguney","year":"2018","unstructured":"Tamguney, G. & Korczyn, A. D. A critical review of the prion hypothesis of human synucleinopathies. Cell Tissue Res. 373, 213\u2013220 (2018).","journal-title":"Cell Tissue Res."},{"key":"1278_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/B978-0-444-63945-5.00017-9","volume":"153","author":"L Volpicelli-Daley","year":"2018","unstructured":"Volpicelli-Daley, L. & Brundin, P. Prion-like propagation of pathology in Parkinson's disease. Handb. Clin. Neurol. 153, 321\u2013335 (2018).","journal-title":"Handb. Clin. Neurol."},{"key":"1278_CR11","doi-asserted-by":"publisher","unstructured":"Rey, N. L., Wesson, D. W. & Brundin, P. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol. Dis. https:\/\/doi.org\/10.1016\/j.nbd.2016.12.013 (2016).","DOI":"10.1016\/j.nbd.2016.12.013"},{"key":"1278_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak, H., Ghebremedhin, E., Rub, U., Bratzke, H. & Del Tredici, K. Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res. 318, 121\u2013134 (2004).","journal-title":"Cell Tissue Res."},{"key":"1278_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1365-2990.2011.01194.x","volume":"37","author":"S Orimo","year":"2011","unstructured":"Orimo, S. et al. Unmyelinated axons are more vulnerable to degeneration than myelinated axons of the cardiac nerve in Parkinson\u2019s disease. Neuropathol. Appl. Neurobiol. 37, 791\u2013802 (2011).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1278_CR14","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00031.2018","volume":"99","author":"C Stadelmann","year":"2019","unstructured":"Stadelmann, C., Timmler, S., Barrantes-Freer, A. & Simons, M. Myelin in the central nervous system: structure, function, and pathology. Physiol. Rev. 99, 1381\u20131431 (2019).","journal-title":"Physiol. Rev."},{"key":"1278_CR15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/hbm.21245","volume":"33","author":"T Hattori","year":"2012","unstructured":"Hattori, T. et al. Cognitive status correlates with white matter alteration in Parkinson\u2019s disease. Hum. Brain Mapp. 33, 727\u2013739 (2012).","journal-title":"Hum. Brain Mapp."},{"key":"1278_CR16","doi-asserted-by":"publisher","first-page":"e003976","DOI":"10.1136\/bmjopen-2013-003976","volume":"4","author":"E Auning","year":"2014","unstructured":"Auning, E. et al. White matter integrity and cognition in Parkinson\u2019s disease: a cross-sectional study. BMJ Open 4, e003976 (2014).","journal-title":"BMJ Open"},{"key":"1278_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s004010051150","volume":"99","author":"H Braak","year":"2000","unstructured":"Braak, H. et al. Parkinson\u2019s disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol. 99, 489\u2013495 (2000).","journal-title":"Acta Neuropathol."},{"key":"1278_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2003.04.001","volume":"25","author":"H Braak","year":"2004","unstructured":"Braak, H. & Del Tredici, K. Poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol. Aging 25, 19\u201323 (2004).","journal-title":"Neurobiol. Aging"},{"key":"1278_CR19","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/brain\/awac002","volume":"145","author":"C Hatton","year":"2022","unstructured":"Hatton, C. et al. Prion-like alpha-synuclein pathology in the brain of infants with Krabbe disease. Brain 145, 1257\u20131263 (2022).","journal-title":"Brain"},{"key":"1278_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17876-0","volume":"11","author":"D Agarwal","year":"2020","unstructured":"Agarwal, D. et al. A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders. Nat. Commun. 11, 4183 (2020).","journal-title":"Nat. Commun."},{"key":"1278_CR21","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41588-020-0610-9","volume":"52","author":"J Bryois","year":"2020","unstructured":"Bryois, J. et al. Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson\u2019s disease. Nat. Genet 52, 482\u2013493 (2020).","journal-title":"Nat. Genet"},{"key":"1278_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41531-019-0076-6","volume":"5","author":"RH Reynolds","year":"2019","unstructured":"Reynolds, R. H. et al. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson\u2019s disease heritability. NPJ Parkinsons Dis. 5, 6 (2019).","journal-title":"NPJ Parkinsons Dis."},{"key":"1278_CR23","doi-asserted-by":"publisher","unstructured":"Smajic, S. et al. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain, https:\/\/doi.org\/10.1093\/brain\/awab446 (2021).","DOI":"10.1093\/brain\/awab446"},{"key":"1278_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s43587-024-00583-6","volume":"4","author":"L Adams","year":"2024","unstructured":"Adams, L., Song, M. K., Yuen, S., Tanaka, Y. & Kim, Y. S. A single-nuclei paired multiomic analysis of the human midbrain reveals age- and Parkinson\u2019s disease-associated glial changes. Nat. Aging 4, 364\u2013378 (2024).","journal-title":"Nat. Aging"},{"key":"1278_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-023-01055-5","volume":"16","author":"EJ Bae","year":"2023","unstructured":"Bae, E. J., Perez-Acuna, D., Rhee, K. H. & Lee, S. J. Changes in oligodendroglial subpopulations in Parkinson\u2019s disease. Mol. Brain 16, 65 (2023).","journal-title":"Mol. Brain"},{"key":"1278_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13024-023-00699-0","volume":"19","author":"A Martirosyan","year":"2024","unstructured":"Martirosyan, A. et al. Unravelling cell type-specific responses to Parkinson\u2019s Disease at single cell resolution. Mol. Neurodegener. 19, 7 (2024).","journal-title":"Mol. Neurodegener."},{"key":"1278_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1017\/S1355617712001373","volume":"19","author":"C Gallagher","year":"2013","unstructured":"Gallagher, C. et al. White matter microstructural integrity and executive function in Parkinson\u2019s disease. J. Int. Neuropsychol. Soc. 19, 349\u2013354 (2013).","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"1278_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41531-024-00647-9","volume":"10","author":"M Camacho","year":"2024","unstructured":"Camacho, M. et al. Exploiting macro- and micro-structural brain changes for improved Parkinson\u2019s disease classification from MRI data. NPJ Parkinsons Dis. 10, 43 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1278_CR29","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.devcel.2015.01.016","volume":"32","author":"KK Bercury","year":"2015","unstructured":"Bercury, K. K. & Macklin, W. B. Dynamics and mechanisms of CNS myelination. Dev. Cell 32, 447\u2013458 (2015).","journal-title":"Dev. Cell"},{"key":"1278_CR30","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1073\/pnas.0813110106","volume":"106","author":"Y min","year":"2009","unstructured":"min, Y. et al. Interaction forces and adhesion of supported myelin lipid bilayers modulated by myelin basic protein. Proc. Natl. Acad. Sci. USA 106, 3154\u20133159 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1278_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fncel.2020.00239","volume":"14","author":"O Jahn","year":"2020","unstructured":"Jahn, O. et al. The CNS Myelin Proteome: Deep Profile and Persistence After Post-mortem Delay. Front. Cell Neurosci. 14, 239 (2020).","journal-title":"Front. Cell Neurosci."},{"key":"1278_CR32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00018-022-04428-6","volume":"79","author":"S Ruskamo","year":"2022","unstructured":"Ruskamo, S. et al. Human myelin proteolipid protein structure and lipid bilayer stacking. Cell Mol. Life Sci. 79, 419 (2022).","journal-title":"Cell Mol. Life Sci."},{"key":"1278_CR33","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00401-023-02621-w","volume":"146","author":"KM Miner","year":"2023","unstructured":"Miner, K. M. et al. The variance in phosphorylated, insoluble \u03b1-synuclein in humans, rats, and mice is not mainly driven by biological sex. Acta Neuropathol. 146, 651\u2013654 (2023).","journal-title":"Acta Neuropathol."},{"key":"1278_CR34","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s13311-021-01114-6","volume":"18","author":"TN Bhatia","year":"2021","unstructured":"Bhatia, T. N. et al. Heat Shock Protein 70 as a Sex-Skewed Regulator of alpha-Synucleinopathy. Neurotherapeutics 18, 2541\u20132564 (2021).","journal-title":"Neurotherapeutics"},{"key":"1278_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102307","volume":"216","author":"KM Miner","year":"2022","unstructured":"Miner, K. M. et al. alpha-synucleinopathy exerts sex-dimorphic effects on the multipurpose DNA repair\/redox protein APE1 in mice and humans. Prog. Neurobiol. 216, 102307 (2022).","journal-title":"Prog. Neurobiol."},{"key":"1278_CR36","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/jnc.12195","volume":"125","author":"G Harauz","year":"2013","unstructured":"Harauz, G. & Boggs, J. M. Myelin management by the 18.5-kDa and 21.5-kDa classic myelin basic protein isoforms. J. Neurochem 125, 334\u2013361 (2013).","journal-title":"J. Neurochem"},{"key":"1278_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jnr.10188","volume":"68","author":"K Akiyama","year":"2002","unstructured":"Akiyama, K., Ichinose, S., Omori, A., Sakurai, Y. & Asou, H. Study of expression of myelin basic proteins (MBPs) in developing rat brain using a novel antibody reacting with four major isoforms of MBP. J. Neurosci. Res. 68, 19\u201328 (2002).","journal-title":"J. Neurosci. Res."},{"key":"1278_CR38","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00018-006-6094-7","volume":"63","author":"JM Boggs","year":"2006","unstructured":"Boggs, J. M. Myelin basic protein: a multifunctional protein. Cell Mol. Life Sci. 63, 1945\u20131961 (2006).","journal-title":"Cell Mol. Life Sci."},{"key":"1278_CR39","doi-asserted-by":"crossref","unstructured":"Rasband, M. N. & Macklin, W. B. in Basic Neurochemistry (Eighth Edition) (eds Scott T. Brady, George J. Siegel, R. Wayne Albers, & Donald L. Price) 180-199 (Academic Press, 2012).","DOI":"10.1016\/B978-0-12-374947-5.00010-9"},{"key":"1278_CR40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.micron.2004.04.005","volume":"35","author":"G Harauz","year":"2004","unstructured":"Harauz, G. et al. Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis. Micron 35, 503\u2013542 (2004).","journal-title":"Micron"},{"key":"1278_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1471-4159.1999.0720001.x","volume":"72","author":"TG Johns","year":"1999","unstructured":"Johns, T. G. & Bernard, C. C. The structure and function of myelin oligodendrocyte glycoprotein. J. Neurochem. 72, 1\u20139 (1999).","journal-title":"J. Neurochem."},{"key":"1278_CR42","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1177\/1352458520964415","volume":"27","author":"Z Zhuo","year":"2021","unstructured":"Zhuo, Z. et al. Brain structural and functional alterations in MOG antibody disease. Mult. Scler. 27, 1350\u20131363 (2021).","journal-title":"Mult. Scler."},{"key":"1278_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/(SICI)1098-1136(199609)18:1<39::AID-GLIA4>3.0.CO;2-Z","volume":"18","author":"SK Solly","year":"1996","unstructured":"Solly, S. K. et al. Myelin\/oligodendrocyte glycoprotein (MOG) expression is associated with myelin deposition. Glia 18, 39\u201348 (1996).","journal-title":"Glia"},{"key":"1278_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","volume":"82","author":"KL Paumier","year":"2015","unstructured":"Paumier, K. L. et al. Intrastriatal injection of pre-formed mouse alpha-synuclein fibrils into rats triggers alpha-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiol. Dis. 82, 185\u2013199 (2015).","journal-title":"Neurobiol. Dis."},{"key":"1278_CR45","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949\u2013953 (2012).","journal-title":"Science"},{"key":"1278_CR46","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.1093\/cercor\/bhab500","volume":"32","author":"DN Bullock","year":"2022","unstructured":"Bullock, D. N. et al. A taxonomy of the brain\u2019s white matter: twenty-one major tracts for the 21st century. Cereb. Cortex 32, 4524\u20134548 (2022).","journal-title":"Cereb. Cortex"},{"key":"1278_CR47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00401-014-1268-0","volume":"127","author":"AN Sacino","year":"2014","unstructured":"Sacino, A. N. et al. Amyloidogenic alpha-synuclein seeds do not invariably induce rapid, widespread pathology in mice. Acta Neuropathol. 127, 645\u2013665 (2014).","journal-title":"Acta Neuropathol."},{"key":"1278_CR48","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/jnen\/nlz070","volume":"78","author":"N Uemura","year":"2019","unstructured":"Uemura, N. et al. Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (alpha-Syn) Pathology in Synthetic alpha-Syn Fibril-Induced Mouse Models of Synucleinopathy. J. Neuropathol. Exp. Neurol. 78, 877\u2013890 (2019).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1278_CR49","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.expneurol.2017.10.017","volume":"299","author":"N Nouraei","year":"2018","unstructured":"Nouraei, N. et al. Critical appraisal of pathology transmission in the alpha-synuclein fibril model of Lewy body disorders. Exp. Neurol. 299, 172\u2013196 (2018).","journal-title":"Exp. Neurol."},{"key":"1278_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0006-8993(97)00761-0","volume":"770","author":"RK Leak","year":"1997","unstructured":"Leak, R. K. & Moore, R. Y. Identification of retinal ganglion cells projecting to the lateral hypothalamic area of the rat. Brain Res. 770, 105\u2013114 (1997).","journal-title":"Brain Res."},{"key":"1278_CR51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00401-024-02781-3","volume":"148","author":"RK Leak","year":"2024","unstructured":"Leak, R. K. et al. Current insights and assumptions on alpha-synuclein in Lewy body disease. Acta Neuropathol. 148, 18 (2024).","journal-title":"Acta Neuropathol."},{"key":"1278_CR52","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W","volume":"61","author":"JL Mason","year":"2000","unstructured":"Mason, J. L. et al. Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination\/remyelination. J. Neurosci. Res. 61, 251\u2013262 (2000).","journal-title":"J. Neurosci. Res."},{"key":"1278_CR53","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/S0002-9440(10)63726-1","volume":"164","author":"JL Mason","year":"2004","unstructured":"Mason, J. L. et al. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am. J. Pathol. 164, 1673\u20131682 (2004).","journal-title":"Am. J. Pathol."},{"key":"1278_CR54","first-page":"1585","volume":"26","author":"T Skripuletz","year":"2011","unstructured":"Skripuletz, T., Gudi, V., Hackstette, D. & Stangel, M. De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. Histol. Histopathol. 26, 1585\u20131597 (2011).","journal-title":"Histol. Histopathol."},{"key":"1278_CR55","doi-asserted-by":"publisher","unstructured":"Kipp, M. How to Use the Cuprizone Model to Study De- and Remyelination. Int. J. Mol. Sci. 25, https:\/\/doi.org\/10.3390\/ijms25031445 (2024).","DOI":"10.3390\/ijms25031445"},{"key":"1278_CR56","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","volume":"11","author":"GK Matsushima","year":"2001","unstructured":"Matsushima, G. K. & Morell, P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11, 107\u2013116 (2001).","journal-title":"Brain Pathol."},{"key":"1278_CR57","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neulet.2009.02.004","volume":"453","author":"M Lindner","year":"2009","unstructured":"Lindner, M., Fokuhl, J., Linsmeier, F., Trebst, C. & Stangel, M. Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination. Neurosci. Lett. 453, 120\u2013125 (2009).","journal-title":"Neurosci. Lett."},{"key":"1278_CR58","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.toxlet.2007.01.010","volume":"169","author":"N Franco-Pons","year":"2007","unstructured":"Franco-Pons, N., Torrente, M., Colomina, M. T. & Vilella, E. Behavioral deficits in the cuprizone-induced murine model of demyelination\/remyelination. Toxicol. Lett. 169, 205\u2013213 (2007).","journal-title":"Toxicol. Lett."},{"key":"1278_CR59","doi-asserted-by":"publisher","first-page":"9074","DOI":"10.1523\/JNEUROSCI.1238-10.2010","volume":"30","author":"L Liu","year":"2010","unstructured":"Liu, L. et al. Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells. J. Neurosci. 30, 9074\u20139083 (2010).","journal-title":"J. Neurosci."},{"key":"1278_CR60","doi-asserted-by":"publisher","first-page":"175909141455195","DOI":"10.1177\/1759091414551955","volume":"6","author":"HH Sachs","year":"2014","unstructured":"Sachs, H. H., Bercury, K. K., Popescu, D. C., Narayanan, S. P. & Macklin, W. B. A new model of cuprizone-mediated demyelination\/remyelination. ASN Neuro 6, 1759091414551955 (2014).","journal-title":"ASN Neuro"},{"key":"1278_CR61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neures.2011.10.002","volume":"72","author":"AJ Steelman","year":"2012","unstructured":"Steelman, A. J., Thompson, J. P. & Li, J. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication. Neurosci. Res. 72, 32\u201342 (2012).","journal-title":"Neurosci. Res."},{"key":"1278_CR62","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1750-3639.2003.tb00032.x","volume":"13","author":"MF Stidworthy","year":"2003","unstructured":"Stidworthy, M. F., Genoud, S., Suter, U., Mantei, N. & Franklin, R. J. Quantifying the early stages of remyelination following cuprizone-induced demyelination. Brain Pathol. 13, 329\u2013339 (2003).","journal-title":"Brain Pathol."},{"key":"1278_CR63","doi-asserted-by":"publisher","first-page":"504","DOI":"10.30802\/AALAS-JAALAS-24-040","volume":"63","author":"AME Skurnack","year":"2024","unstructured":"Skurnack, A. M. E. et al. Voluntary Wheel Running an Effective Intervention in the Management of Excessive Food Usage in CD-1 Mice (Mus musculus). J. Am. Assoc. Lab Anim. Sci. 63, 504\u2013512 (2024).","journal-title":"J. Am. Assoc. Lab Anim. Sci."},{"key":"1278_CR64","doi-asserted-by":"publisher","unstructured":"Zhan, J. et al. The Cuprizone Model: dos and do nots. Cells 9, https:\/\/doi.org\/10.3390\/cells9040843 (2020).","DOI":"10.3390\/cells9040843"},{"key":"1278_CR65","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/978-1-4939-9072-6_21","volume":"1936","author":"CE McMurran","year":"2019","unstructured":"McMurran, C. E., Zhao, C. & Franklin, R. J. M. Toxin-Based Models to Investigate Demyelination and Remyelination. Methods Mol. Biol. 1936, 377\u2013396 (2019).","journal-title":"Methods Mol. Biol."},{"key":"1278_CR66","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12031-015-0595-5","volume":"57","author":"J Goldberg","year":"2015","unstructured":"Goldberg, J., Clarner, T., Beyer, C. & Kipp, M. Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice. J. Mol. Neurosci. 57, 166\u2013175 (2015).","journal-title":"J. Mol. Neurosci."},{"key":"1278_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroimage.2016.11.008","volume":"146","author":"NS Hubner","year":"2017","unstructured":"Hubner, N. S. et al. The connectomics of brain demyelination: Functional and structural patterns in the cuprizone mouse model. NeuroImage 146, 1\u201318 (2017).","journal-title":"NeuroImage"},{"key":"1278_CR68","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/cne.22330","volume":"518","author":"L Silvestroff","year":"2010","unstructured":"Silvestroff, L. et al. Cuprizone-induced demyelination in CNP::GFP transgenic mice. J. Comp. Neurol. 518, 2261\u20132283 (2010).","journal-title":"J. Comp. Neurol."},{"key":"1278_CR69","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/1570159X15666170717120343","volume":"17","author":"JM Vega-Riquer","year":"2019","unstructured":"Vega-Riquer, J. M., Mendez-Victoriano, G., Morales-Luckie, R. A. & Gonzalez-Perez, O. Five Decades of Cuprizone, an Updated Model to Replicate Demyelinating Diseases. Curr. Neuropharmacol. 17, 129\u2013141 (2019).","journal-title":"Curr. Neuropharmacol."},{"key":"1278_CR70","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.brainres.2009.03.011","volume":"1270","author":"HJ Yang","year":"2009","unstructured":"Yang, H. J. et al. Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia. Brain Res. 1270, 121\u2013130 (2009).","journal-title":"Brain Res."},{"key":"1278_CR71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13578-017-0181-3","volume":"7","author":"Q Yu","year":"2017","unstructured":"Yu, Q. et al. Strain differences in cuprizone induced demyelination. Cell Biosci. 7, 59 (2017).","journal-title":"Cell Biosci."},{"key":"1278_CR72","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0165-5728(98)00168-4","volume":"92","author":"MM Hiremath","year":"1998","unstructured":"Hiremath, M. M. et al. Microglial\/macrophage accumulation during cuprizone-induced demyelination in C57BL\/6 mice. J. Neuroimmunol. 92, 38\u201349 (1998).","journal-title":"J. Neuroimmunol."},{"key":"1278_CR73","doi-asserted-by":"publisher","unstructured":"Rey, N. L. et al. Widespread transneuronal propagation of alpha-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson\u2019s disease. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20160368 (2016).","DOI":"10.1084\/jem.20160368"},{"key":"1278_CR74","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1002\/cne.22662","volume":"519","author":"PC Brunjes","year":"2011","unstructured":"Brunjes, P. C., Kay, R. B. & Arrivillaga, J. P. The mouse olfactory peduncle. J. Comp. Neurol. 519, 2870\u20132886 (2011).","journal-title":"J. Comp. Neurol."},{"key":"1278_CR75","doi-asserted-by":"publisher","first-page":"e87736","DOI":"10.1371\/journal.pone.0087736","volume":"9","author":"B Bagchi","year":"2014","unstructured":"Bagchi, B. et al. Disruption of myelin leads to ectopic expression of K(V)1.1 channels with abnormal conductivity of optic nerve axons in a cuprizone-induced model of demyelination. PLoS One 9, e87736 (2014).","journal-title":"PLoS One"},{"key":"1278_CR76","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/brb3.61","volume":"2","author":"M Ikeda","year":"2012","unstructured":"Ikeda, M. & Oka, Y. The relationship between nerve conduction velocity and fiber morphology during peripheral nerve regeneration. Brain Behav. 2, 382\u2013390 (2012).","journal-title":"Brain Behav."},{"key":"1278_CR77","doi-asserted-by":"publisher","unstructured":"Bhatia, T. N. et al. A 14-day pulse of PLX5622 modifies alpha-synucleinopathy in preformed fibril-infused aged mice of both sexes. Neurobiol Dis, 106196, https:\/\/doi.org\/10.1016\/j.nbd.2023.106196 (2023).","DOI":"10.1016\/j.nbd.2023.106196"},{"key":"1278_CR78","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neulet.2009.02.006","volume":"453","author":"L Silveira-Moriyama","year":"2009","unstructured":"Silveira-Moriyama, L. et al. Regional differences in the severity of Lewy body pathology across the olfactory cortex. Neurosci. Lett. 453, 77\u201380 (2009).","journal-title":"Neurosci. Lett."},{"key":"1278_CR79","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/mds.26605","volume":"31","author":"CH Adler","year":"2016","unstructured":"Adler, C. H. & Beach, T. G. Neuropathological basis of nonmotor manifestations of Parkinson\u2019s disease. Mov. Disord. 31, 1114\u20131119 (2016).","journal-title":"Mov. Disord."},{"key":"1278_CR80","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/bpa.12718","volume":"29","author":"DM Mason","year":"2019","unstructured":"Mason, D. M. et al. The center of olfactory bulb-seeded alpha-synucleinopathy is the limbic system and the ensuing pathology is higher in male than in female mice. Brain Pathol. 29, 741\u2013770 (2019).","journal-title":"Brain Pathol."},{"key":"1278_CR81","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1016\/j.neuron.2023.11.020","volume":"111","author":"LA Parra-Rivas","year":"2023","unstructured":"Parra-Rivas, L. A. et al. Serine-129 phosphorylation of alpha-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function. Neuron 111, 4006\u20134023.e4010 (2023).","journal-title":"Neuron"},{"key":"1278_CR82","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41531-023-00444-w","volume":"9","author":"N Ramalingam","year":"2023","unstructured":"Ramalingam, N. et al. Dynamic physiological alpha-synuclein S129 phosphorylation is driven by neuronal activity. NPJ Parkinsons Dis. 9, 4 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1278_CR83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41531-023-00491-3","volume":"9","author":"BA Killinger","year":"2023","unstructured":"Killinger, B. A. et al. Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesis. NPJ Parkinsons Dis. 9, 43 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1278_CR84","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1093\/brain\/awf251","volume":"125","author":"AJ Harding","year":"2002","unstructured":"Harding, A. J., Stimson, E., Henderson, J. M. & Halliday, G. M. Clinical correlates of selective pathology in the amygdala of patients with Parkinson\u2019s disease. Brain 125, 2431\u20132445 (2002).","journal-title":"Brain"},{"key":"1278_CR85","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neulet.2016.11.035","volume":"637","author":"LS Hsieh","year":"2017","unstructured":"Hsieh, L. S., Wen, J. H., Miyares, L., Lombroso, P. J. & Bordey, A. Outbred CD1 mice are as suitable as inbred C57BL\/6J mice in performing social tasks. Neurosci. Lett. 637, 142\u2013147 (2017).","journal-title":"Neurosci. Lett."},{"key":"1278_CR86","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41531-023-00574-1","volume":"9","author":"DJ Dues","year":"2023","unstructured":"Dues, D. J., Nguyen, A. P. T., Becker, K., Ma, J. & Moore, D. J. Hippocampal subfield vulnerability to alpha-synuclein pathology precedes neurodegeneration and cognitive dysfunction. NPJ Parkinsons Dis. 9, 125 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1278_CR87","doi-asserted-by":"publisher","first-page":"e0163774","DOI":"10.1371\/journal.pone.0163774","volume":"11","author":"DC Dean","year":"2016","unstructured":"Dean, D. C. et al. Alterations of Myelin Content in Parkinson\u2019s Disease: A Cross-Sectional Neuroimaging Study. PLoS One 11, e0163774 (2016).","journal-title":"PLoS One"},{"key":"1278_CR88","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41531-023-00592-z","volume":"9","author":"K Yang","year":"2023","unstructured":"Yang, K. et al. White matter changes in Parkinson\u2019s disease. NPJ Parkinsons Dis. 9, 150 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1278_CR89","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1002\/mds.23208","volume":"25","author":"N Ibarretxe-Bilbao","year":"2010","unstructured":"Ibarretxe-Bilbao, N. et al. Olfactory impairment in Parkinson\u2019s disease and white matter abnormalities in central olfactory areas: A voxel-based diffusion tensor imaging study. Mov. Disord. 25, 1888\u20131894 (2010).","journal-title":"Mov. Disord."},{"key":"1278_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-017-0367-y","volume":"18","author":"PL Chiang","year":"2017","unstructured":"Chiang, P. L. et al. White matter damage and systemic inflammation in Parkinson\u2019s disease. BMC Neurosci. 18, 48 (2017).","journal-title":"BMC Neurosci."},{"key":"1278_CR91","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ejrad.2009.07.032","volume":"77","author":"K Zhang","year":"2011","unstructured":"Zhang, K. et al. Voxel-based analysis of diffusion tensor indices in the brain in patients with Parkinson\u2019s disease. Eur. J. Radio. 77, 269\u2013273 (2011).","journal-title":"Eur. J. Radio."},{"key":"1278_CR92","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jns.2017.12.018","volume":"385","author":"H Joki","year":"2018","unstructured":"Joki, H. et al. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson\u2019s disease with dementia, and Alzheimer\u2019s disease. J. Neurol. Sci. 385, 99\u2013104 (2018).","journal-title":"J. Neurol. Sci."},{"key":"1278_CR93","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/brain\/awh493","volume":"128","author":"M Bozzali","year":"2005","unstructured":"Bozzali, M. et al. Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study. Brain 128, 1595\u20131604 (2005).","journal-title":"Brain"},{"key":"1278_CR94","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.neurobiolaging.2015.03.007","volume":"36","author":"Z Nedelska","year":"2015","unstructured":"Nedelska, Z. et al. White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging. Neurobiol. Aging 36, 2010\u20132017 (2015).","journal-title":"Neurobiol. Aging"},{"key":"1278_CR95","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00415-024-12747-w","volume":"272","author":"F Maass","year":"2024","unstructured":"Maass, F. et al. Myelin basic protein and TREM2 quantification in the CSF of patients with Multiple System Atrophy and other Parkinsonian conditions. J. Neurol. 272, 52 (2024).","journal-title":"J. Neurol."},{"key":"1278_CR96","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi8287","volume":"10","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson\u2019s disease. Sci. Adv. 10, eadi8287 (2024).","journal-title":"Sci. Adv."},{"key":"1278_CR97","doi-asserted-by":"publisher","first-page":"e3002977","DOI":"10.1371\/journal.pbio.3002977","volume":"23","author":"JM Salazar Campos","year":"2025","unstructured":"Salazar Campos, J. M., Burbulla, L. F. & Jakel, S. Are oligodendrocytes bystanders or drivers of Parkinson\u2019s disease pathology? PLoS Biol. 23, e3002977 (2025).","journal-title":"PLoS Biol."},{"key":"1278_CR98","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.16298","volume":"169","author":"JC Fitzgerald","year":"2025","unstructured":"Fitzgerald, J. C. et al. Interactions of Oligodendrocyte Precursor Cells and Dopaminergic Neurons in the Mouse Substantia Nigra. J. Neurochem 169, e16298 (2025).","journal-title":"J. Neurochem"},{"key":"1278_CR99","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1126\/science.7433992","volume":"210","author":"AA Grace","year":"1980","unstructured":"Grace, A. A. & Bunney, B. S. Nigral dopamine neurons: intracellular recording and identification with L-dopa injection and histofluorescence. Science 210, 654\u2013656 (1980).","journal-title":"Science"},{"key":"1278_CR100","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41531-024-00672-8","volume":"10","author":"HM Geertsma","year":"2024","unstructured":"Geertsma, H. M. et al. A topographical atlas of alpha-synuclein dosage and cell type-specific expression in adult mouse brain and peripheral organs. NPJ Parkinsons Dis. 10, 65 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1278_CR101","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/glia.22653","volume":"62","author":"YT Asi","year":"2014","unstructured":"Asi, Y. T. et al. Alpha-synuclein mRNA expression in oligodendrocytes in MSA. Glia 62, 964\u2013970 (2014).","journal-title":"Glia"},{"key":"1278_CR102","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/glia.22611","volume":"62","author":"JF Reyes","year":"2014","unstructured":"Reyes, J. F. et al. Alpha-synuclein transfers from neurons to oligodendrocytes. Glia 62, 387\u2013398 (2014).","journal-title":"Glia"},{"key":"1278_CR103","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ana.21465","volume":"64","author":"GK Wenning","year":"2008","unstructured":"Wenning, G. K., Stefanova, N., Jellinger, K. A., Poewe, W. & Schlossmacher, M. G. Multiple system atrophy: a primary oligodendrogliopathy. Ann. Neurol. 64, 239\u2013246 (2008).","journal-title":"Ann. Neurol."},{"key":"1278_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106551","volume":"198","author":"T Kon","year":"2024","unstructured":"Kon, T. et al. SNCA and TPPP transcripts increase in oligodendroglial cytoplasmic inclusions in multiple system atrophy. Neurobiol. Dis. 198, 106551 (2024).","journal-title":"Neurobiol. Dis."},{"key":"1278_CR105","doi-asserted-by":"publisher","first-page":"e24834","DOI":"10.1371\/journal.pone.0024834","volume":"6","author":"C Rieker","year":"2011","unstructured":"Rieker, C. et al. Neuropathology in mice expressing mouse alpha-synuclein. PLoS One 6, e24834 (2011).","journal-title":"PLoS One"},{"key":"1278_CR106","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson, B. I. et al. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34, 521\u2013533 (2002).","journal-title":"Neuron"},{"key":"1278_CR107","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-021-01131-8","volume":"9","author":"N Ferreira","year":"2021","unstructured":"Ferreira, N. et al. Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain. Acta Neuropathol. Commun. 9, 31 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"1278_CR108","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1523\/JNEUROSCI.20-16-06021.2000","volume":"20","author":"H van der Putten","year":"2000","unstructured":"van der Putten, H. et al. Neuropathology in mice expressing human alpha-synuclein. J. Neurosci. 20, 6021\u20136029 (2000).","journal-title":"J. Neurosci."},{"key":"1278_CR109","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0304-3940(98)00890-8","volume":"259","author":"T Arai","year":"1999","unstructured":"Arai, T. et al. Argyrophilic glial inclusions in the midbrain of patients with Parkinson\u2019s disease and diffuse Lewy body disease are immunopositive for NACP\/alpha-synuclein. Neurosci. Lett. 259, 83\u201386 (1999).","journal-title":"Neurosci. Lett."},{"key":"1278_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63412-x","volume":"10","author":"TJ Stevenson","year":"2020","unstructured":"Stevenson, T. J. et al. alpha-synuclein inclusions are abundant in non-neuronal cells in the anterior olfactory nucleus of the Parkinson\u2019s disease olfactory bulb. Sci. Rep. 10, 6682 (2020).","journal-title":"Sci. Rep."},{"key":"1278_CR111","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.brainresrev.2005.08.005","volume":"50","author":"PC Brunjes","year":"2005","unstructured":"Brunjes, P. C., Illig, K. R. & Meyer, E. A. A field guide to the anterior olfactory nucleus (cortex). Brain Res. Brain Res Rev. 50, 305\u2013335 (2005).","journal-title":"Brain Res. Brain Res Rev."},{"key":"1278_CR112","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/cne.24452","volume":"526","author":"LN Collins","year":"2018","unstructured":"Collins, L. N., Hill, D. L. & Brunjes, P. C. Myelination of the developing lateral olfactory tract and anterior commissure. J. Comp. Neurol. 526, 1843\u20131858 (2018).","journal-title":"J. Comp. Neurol."},{"key":"1278_CR113","unstructured":"Paxinos, G. & Franklin, K. B. J. Paxinos and Franklin\u2019s The mouse brain in stereotaxic coordinates. Fourth edition. edn, (Academic Press, an imprint of Elsevier, 2013)."},{"key":"1278_CR114","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00401-008-0450-7","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach, T. G. et al. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol. 117, 169\u2013174 (2009).","journal-title":"Acta Neuropathol."},{"key":"1278_CR115","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00401-010-0687-9","volume":"119","author":"I Ubeda-Banon","year":"2010","unstructured":"Ubeda-Banon, I. et al. alpha-Synucleinopathy in the human olfactory system in Parkinson\u2019s disease: involvement of calcium-binding protein- and substance P-positive cells. Acta Neuropathol. 119, 723\u2013735 (2010).","journal-title":"Acta Neuropathol."},{"key":"1278_CR116","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mds.870100309","volume":"10","author":"RK Pearce","year":"1995","unstructured":"Pearce, R. K., Hawkes, C. H. & Daniel, S. E. The anterior olfactory nucleus in Parkinson\u2019s disease. Mov. Disord. 10, 283\u2013287 (1995).","journal-title":"Mov. Disord."},{"key":"1278_CR117","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13024-016-0113-4","volume":"11","author":"DM Mason","year":"2016","unstructured":"Mason, D. M. et al. Transmission of alpha-synucleinopathy from olfactory structures deep into the temporal lobe. Mol. Neurodegener. 11, 49 (2016).","journal-title":"Mol. Neurodegener."},{"key":"1278_CR118","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cmet.2023.12.022","volume":"36","author":"MP Mattson","year":"2024","unstructured":"Mattson, M. P. & Leak, R. K. The hormesis principle of neuroplasticity and neuroprotection. Cell Metab. 36, 315\u2013337 (2024).","journal-title":"Cell Metab."},{"key":"1278_CR119","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1073\/pnas.86.14.5661","volume":"86","author":"M Kimura","year":"1989","unstructured":"Kimura, M. et al. Restoration of myelin formation by a single type of myelin basic protein in transgenic shiverer mice. Proc. Natl. Acad. Sci. USA 86, 5661\u20135665 (1989).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1278_CR120","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/oxfordjournals.jhered.a109442","volume":"72","author":"GF Chernoff","year":"1981","unstructured":"Chernoff, G. F. Shiverer: an autosomal recessive mutant mouse with myelin deficiency. J. Hered. 72, 128 (1981).","journal-title":"J. Hered."},{"key":"1278_CR121","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF01067791","volume":"20","author":"C Readhead","year":"1990","unstructured":"Readhead, C. & Hood, L. The dysmyelinating mouse mutations shiverer (shi) and myelin-deficient (shimld). Behav. Genet. 20, 213\u2013234 (1990).","journal-title":"Behav. Genet."},{"key":"1278_CR122","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/glia.23039","volume":"64","author":"G Poggi","year":"2016","unstructured":"Poggi, G. et al. Cortical network dysfunction caused by a subtle defect of myelination. Glia 64, 2025\u20132040 (2016).","journal-title":"Glia"},{"key":"1278_CR123","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1111\/j.1471-4159.1983.tb08142.x","volume":"40","author":"E Barbarese","year":"1983","unstructured":"Barbarese, E., Nielson, M. L. & Carson, J. H. The effect of the shiverer mutation on myelin basic protein expression in homozygous and heterozygous mouse brain. J. Neurochem. 40, 1680\u20131686 (1983).","journal-title":"J. Neurochem."},{"key":"1278_CR124","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1002\/jnr.21086","volume":"84","author":"M Martin","year":"2006","unstructured":"Martin, M. et al. Myelin deficiencies visualized in vivo: visually evoked potentials and T2-weighted magnetic resonance images of shiverer mutant and wild-type mice. J. Neurosci. Res. 84, 1716\u20131726 (2006).","journal-title":"J. Neurosci. Res."},{"key":"1278_CR125","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1111\/j.1471-4159.1984.tb02797.x","volume":"42","author":"W Cammer","year":"1984","unstructured":"Cammer, W., Kahn, S. & Zimmerman, T. Biochemical abnormalities in spinal cord myelin and CNS homogenates in heterozygotes affected by the shiverer mutation. J. Neurochem. 42, 1372\u20131378 (1984).","journal-title":"J. Neurochem."},{"key":"1278_CR126","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.nbd.2010.03.016","volume":"39","author":"LC Taylor","year":"2010","unstructured":"Taylor, L. C., Puranam, K., Gilmore, W., Ting, J. P. & Matsushima, G. K. 17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss. Neurobiol. Dis. 39, 127\u2013137 (2010).","journal-title":"Neurobiol. Dis."},{"key":"1278_CR127","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/jnr.22215","volume":"88","author":"LC Taylor","year":"2010","unstructured":"Taylor, L. C., Gilmore, W., Ting, J. P. & Matsushima, G. K. Cuprizone induces similar demyelination in male and female C57BL\/6 mice and results in disruption of the estrous cycle. J. Neurosci. Res. 88, 391\u2013402 (2010).","journal-title":"J. Neurosci. Res."},{"key":"1278_CR128","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ab.10035","volume":"29","author":"PLP Van Loo","year":"2003","unstructured":"Van Loo, P. L. P. et al. Strain-specific aggressive behavior of male mice submitted to different husbandry procedures. Aggress. Behav. 29, 69\u201380 (2003).","journal-title":"Aggress. Behav."},{"key":"1278_CR129","doi-asserted-by":"publisher","unstructured":"Cum, M. et al. A Multiparadigm Approach to Characterize Dominance Behaviors in CD1 and C57BL6 Male Mice. eNeuro 11, https:\/\/doi.org\/10.1523\/ENEURO.0342-24.2024 (2024).","DOI":"10.1523\/ENEURO.0342-24.2024"},{"key":"1278_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51674-z","volume":"9","author":"K Lidster","year":"2019","unstructured":"Lidster, K., Owen, K., Browne, W. J. & Prescott, M. J. Cage aggression in group-housed laboratory male mice: an international data crowdsourcing project. Sci. Rep. 9, 15211 (2019).","journal-title":"Sci. Rep."},{"key":"1278_CR131","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JPD-171248","volume":"8","author":"NK Polinski","year":"2018","unstructured":"Polinski, N. K. et al. Best practices for generating and using Alpha-synuclein pre-formed fibrils to Model Parkinson\u2019s disease in rodents. J. Parkinsons Dis. 8, 303\u2013322 (2018).","journal-title":"J. Parkinsons Dis."},{"key":"1278_CR132","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley, L. A., Luk, K. C. & Lee, V. M. Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates. Nat. Protoc. 9, 2135\u20132146 (2014).","journal-title":"Nat. Protoc."},{"key":"1278_CR133","doi-asserted-by":"crossref","unstructured":"Arbuckle, E. P., Smith, G. D., Gomez, M. C. & Lugo, J. N. Testing for odor discrimination and habituation in mice. JoVE (J. Vis. Exp.), e52615 (2015).","DOI":"10.3791\/52615-v"},{"key":"1278_CR134","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1006\/nlme.1999.3919","volume":"73","author":"F Dellu","year":"2000","unstructured":"Dellu, F., Contarino, A., Simon, H., Koob, G. & Gold, L. Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiol. Learn. Mem. 73, 31\u201348 (2000).","journal-title":"Neurobiol. Learn. Mem."},{"key":"1278_CR135","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbr.2015.10.049","volume":"298","author":"M Gross","year":"2016","unstructured":"Gross, M. & Pinhasov, A. Chronic mild stress in submissive mice: Marked polydipsia and social avoidance without hedonic deficit in the sucrose preference test. Behav. Brain Res. 298, 25\u201334 (2016).","journal-title":"Behav. Brain Res."},{"key":"1278_CR136","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0196-9781(86)90076-8","volume":"7","author":"RE Watson Jr.","year":"1986","unstructured":"Watson, R. E. Jr., Wiegand, S. J., Clough, R. W. & Hoffman, G. E. Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides 7, 155\u2013159 (1986).","journal-title":"Peptides"},{"key":"1278_CR137","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.biopsych.2010.04.030","volume":"69","author":"KA Dorph-Petersen","year":"2011","unstructured":"Dorph-Petersen, K. A. & Lewis, D. A. Stereological approaches to identifying neuropathology in psychosis. Biol. Psychiatry 69, 113\u2013126 (2011).","journal-title":"Biol. Psychiatry"},{"key":"1278_CR138","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jim.2005.12.002","volume":"309","author":"MS Petersen","year":"2006","unstructured":"Petersen, M. S., Petersen, C. C., Agger, R., Hokland, M. & Gundersen, H. J. A simple method for unbiased quantitation of adoptively transferred cells in solid tissues. J. Immunol. Methods 309, 173\u2013181 (2006).","journal-title":"J. Immunol. Methods"},{"key":"1278_CR139","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1365-2818.1999.00457.x","volume":"193","author":"HJ Gundersen","year":"1999","unstructured":"Gundersen, H. J., Jensen, E. B., Kieu, K. & Nielsen, J. The efficiency of systematic sampling in stereology-reconsidered. J. Microsc 193, 199\u2013211 (1999).","journal-title":"J. Microsc"},{"key":"1278_CR140","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/nn.3809","volume":"17","author":"B Beirowski","year":"2014","unstructured":"Beirowski, B. et al. Metabolic regulator LKB1 is crucial for Schwann cell\u2013mediated axon maintenance. Nat. Neurosci. 17, 1351\u20131361 (2014).","journal-title":"Nat. Neurosci."},{"key":"1278_CR141","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-2-49","volume":"2","author":"E Cognat","year":"2014","unstructured":"Cognat, E., Cleophax, S., Domenga-Denier, V. & Joutel, A. Early white matter changes in CADASIL: evidence of segmental intramyelinic oedema in a pre-clinical mouse model. Acta Neuropathol. Commun. 2, 49 (2014).","journal-title":"Acta Neuropathol. Commun."},{"key":"1278_CR142","doi-asserted-by":"publisher","first-page":"E4261","DOI":"10.1073\/pnas.1620761114","volume":"114","author":"B Beirowski","year":"2017","unstructured":"Beirowski, B., Wong, K. M., Babetto, E. & Milbrandt, J. mTORC1 promotes proliferation of immature Schwann cells and myelin growth of differentiated Schwann cells. Proc. Natl. Acad. Sci. 114, E4261\u2013E4270 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1278_CR143","doi-asserted-by":"publisher","first-page":"8953","DOI":"10.1523\/JNEUROSCI.0219-10.2010","volume":"30","author":"S Goebbels","year":"2010","unstructured":"Goebbels, S. et al. Elevated phosphatidylinositol 3, 4, 5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination. J. Neurosci. 30, 8953\u20138964 (2010).","journal-title":"J. Neurosci."},{"key":"1278_CR144","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.1073\/pnas.171300598","volume":"98","author":"R Sharon","year":"2001","unstructured":"Sharon, R. et al. alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proc. Natl. Acad. Sci. USA 98, 9110\u20139115 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01278-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01278-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01278-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:05:57Z","timestamp":1774541157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01278-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":144,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1278"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01278-y","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}